Pediatrics · Infectious Disease · 3 h ago
AAP report outlines influenza prevention and treatment guidance for children in 2026–2027
The American Academy of Pediatrics’ technical report accompanies its recommendations on influenza vaccination and antiviral use in children for the 2026–2027 season. It supports annual vaccination for children from 6 months of age without medical contraindications and summarizes evidence and implementation guidance.
- AAP recommends annual influenza vaccination from 6 months of age.
- Report reviews vaccines, testing and antiviral treatment and prevention.
- Uptake strategies and vaccine implementation are also addressed.
The American Academy of Pediatrics (AAP) technical report accompanies its recommendations for preventing and treating influenza in children during the 2026–2027 season. It reviews recent influenza seasons, pediatric morbidity and mortality, vaccine effectiveness and coverage, and the rationale for annual influenza vaccination of all children without medical contraindications starting at 6 months of age.
The report also addresses vaccine storage, administration and implementation; available vaccine types; vaccination during pregnancy and breastfeeding; influenza diagnostic testing; and antiviral medications for treatment and chemoprophylaxis. Strategies to increase vaccine uptake are emphasized.
The supplied abstract does not provide specific antiviral regimens, vaccine product details or evidence estimates. The report is intended to inform seasonal pediatric influenza prevention and management, but clinicians should consult the full report and accompanying AAP recommendations for detailed guidance.
In practice
The AAP report supports annual influenza vaccination for children aged 6 months and older who have no medical contraindications, and summarizes seasonal guidance on vaccine implementation, testing and antiviral treatment or chemoprophylaxis. This is professional-society guidance for the 2026–2027 season, not evidence of a new regulatory change. The supplied abstract does not include product-specific recommendations, antiviral regimens or supporting effect estimates, so those details cannot be assessed here; consult the full report for application to individual patients.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Pediatrics: Recommendations for Prevention and Control of Influenza in Children, 2026–2027: Technical Report ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.